Northwire Canada EditionSunday, October 18, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Regulatory

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing

BLO · Price

Executive Summary

  • Cannabix Technologies’ Breath Collection Unit (BCU) passed FCC electronic emissions testing and Canadian ISED standards, clearing a key regulatory hurdle for U.S. and Canadian market entry.
  • The successful test was conducted by ISO/IEC 17025‑accredited QAI Laboratories, providing an official compliance report under CFR Title 47 Part 15 and ICES‑003 Issue 7.
  • Completion of emissions testing advances the commercialization timeline for the Marijuana Breath Test (MBT) system, which pairs the BCU with proprietary breath cartridges for forensic THC detection.

Key Details

  • Regulatory Approval: FCC Part 15 (U.S.) and ISED ICES‑003 Issue 7 (Canada) electronic emissions standards met; ISO/IEC 17025 accredited test report issued.
  • Testing Facility: QAI Laboratories, British Columbia – holds Telecommunication Certification Body (TCB) designation and recognized for electrical safety evaluations in both markets.
  • Product Description: Handheld Breath Collection Unit (BCU) plus proprietary Breath Cartridges form the core hardware of the MBT system, designed to collect stable breath samples for LC‑MS analysis of recent marijuana use.
  • Strategic Partnership: Omega Laboratories Inc., a global forensic drug‑testing leader, will support commercialization and analytical validation of the MBT system in the U.S. and Canada.
  • Commercialization Impact: Passing emissions testing removes a critical barrier to market entry, allowing Cannabix to proceed with regulatory filings, manufacturing scale‑up, and sales efforts for workplaces, law enforcement, and other settings.
  • Forward‑Looking Statements: Company anticipates continued regulatory steps, potential additional agreements with distributors, and future financing to support product launch; risks include market conditions, technology protection, and successful completion of further approvals.

Notable Quotes

“The successful emissions testing of our Breath Collection Unit is a pivotal milestone that brings us significantly closer to delivering a reliable, compliant solution for detecting recent marijuana use in the workplace and law‑enforcement environments.” – Rav Mlait, CEO, Cannabix Technologies Inc.

Read the original news release →

More from Cannabix Technologies Inc.